Trinity Biotech (TRIB) Accounts Payables (2016 - 2024)
Trinity Biotech (TRIB) has disclosed Accounts Payables for 9 consecutive years, with $26.8 million as the latest value for Q4 2024.
- Quarterly Accounts Payables rose 589.37% to $26.8 million in Q4 2024 from the year-ago period, while the trailing twelve-month figure was $26.8 million through Dec 2024, up 589.37% year-over-year, with the annual reading at $26.8 million for FY2024, 589.37% up from the prior year.
- Accounts Payables hit $26.8 million in Q4 2024 for Trinity Biotech, up from $3.9 million in the prior quarter.
- In the past five years, Accounts Payables ranged from a high of $26.8 million in Q4 2024 to a low of $3.9 million in Q4 2023.
- Historically, Accounts Payables has averaged $11.8 million across 5 years, with a median of $7.1 million in 2020.
- Biggest five-year swings in Accounts Payables: tumbled 58.98% in 2022 and later skyrocketed 589.37% in 2024.
- Year by year, Accounts Payables stood at $7.1 million in 2020, then skyrocketed by 112.97% to $15.1 million in 2021, then crashed by 58.98% to $6.2 million in 2022, then plummeted by 37.39% to $3.9 million in 2023, then surged by 589.37% to $26.8 million in 2024.
- Business Quant data shows Accounts Payables for TRIB at $26.8 million in Q4 2024, $3.9 million in Q4 2023, and $6.2 million in Q4 2022.